Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Multiple Endocrine Neoplasia Type 1 5Neoplasms 2Skin Neoplasms 1Rosacea 1Psoriasis 1Pregnancy Complications 1Neurologic Manifestations 1Motor Activity 1Metabolic Diseases 1Melanoma 1Inflammation 1Feeding Behavior 1Esophageal Neoplasms 1Endocrine System Diseases 1Diabetes Mellitus 1Dermatitis, Atopic 1Colorectal Neoplasms 1Cerebrovascular Disorders 1Cardiovascular Diseases 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Eating × Clear all
NCT06234267 2025-05-23

Eat, Play, Sleep: A Text Message Approach to Promoting Health Behaviors for Cancer Survivors and Their Caregivers

University of Arizona

Phase NA Completed
44 enrolled
Tumor-Agnostic

Neoplasms

NCT03328546 2023-04-14

Dietary Patterns and Health Outcomes (Cardiovascular, Metabolic, Endocrine, Neurological, Skeletal Muscular, Cancer)

Harvard School of Public Health (HSPH)

Completed
116,671 enrolled

Cardiovascular Diseases, Cerebrovascular Disorders, Diabetes Mellitus, Endocrine System Diseases, Metabolic Diseases, Neoplasms, Neurologic Manifestations, Pregnancy Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡